688276 百克生物
已收盘 08-16 15:00:00
资讯
新帖
简况
百克生物(688276)2024年中报简析:营收净利润同比双双增长,应收账款上升
证券之星 · 06:07
百克生物(688276)2024年中报简析:营收净利润同比双双增长,应收账款上升
百克生物: 未来公司如有回购相关事项,公司将及时履行信息披露义务
证星董秘互动 · 08-16 18:01
百克生物: 未来公司如有回购相关事项,公司将及时履行信息披露义务
百克生物:8月16日接受机构调研,中信医药、国信医药等多家机构参与
证星公司调研 · 08-16 17:04
百克生物:8月16日接受机构调研,中信医药、国信医药等多家机构参与
8月16日百克生物创60日新低,招商前沿医疗保健股票A基金重仓该股
证券之星 · 08-16 16:12
8月16日百克生物创60日新低,招商前沿医疗保健股票A基金重仓该股
北向资金8月15日净卖出百克生物14.36万股 连续3日减持
自选股智能写手 · 08-16 09:30
北向资金8月15日净卖出百克生物14.36万股 连续3日减持
百克生物大跌5.05% 北向资金连续3日减持
智选洞察 · 08-16 09:30
百克生物大跌5.05% 北向资金连续3日减持
图解百克生物中报:第二季度单季净利润同比减17.16%
证券之星 · 08-15 17:10
图解百克生物中报:第二季度单季净利润同比减17.16%
百克生物(688276)6月30日股东户数1.11万户,较上期增加33.46%
证券之星 · 08-15 17:01
百克生物(688276)6月30日股东户数1.11万户,较上期增加33.46%
百克生物公布半年报 上半年净利增加23.54%
智能小浪 · 08-15 16:20
百克生物公布半年报 上半年净利增加23.54%
百克生物最新公告:上半年净利润同比增长23.54%
证券之星 · 08-15 16:13
百克生物最新公告:上半年净利润同比增长23.54%
百克生物(688276.SH)发布上半年业绩,净利润1.38亿元,增长23.54%
智通财经 · 08-15 15:40
百克生物(688276.SH)发布上半年业绩,净利润1.38亿元,增长23.54%
【百克生物:2024年上半年净利润同比增长23.54%】金十数据8月15日讯,百克生物公告,公司2024年上半年实现营业收入6.
美港电讯 · 08-15 15:39
【百克生物:2024年上半年净利润同比增长23.54%】金十数据8月15日讯,百克生物公告,公司2024年上半年实现营业收入6.
百克生物:2024年上半年净利润同比增长23.54%
财通社 · 08-15 15:38
百克生物:2024年上半年净利润同比增长23.54%
生物疫苗概念盘中拉升,博晖创新涨3.80%
自选股智能写手 · 08-15 10:26
生物疫苗概念盘中拉升,博晖创新涨3.80%
A股生物制品持续下挫,康乐卫士跌近7%,智翔金泰、百普赛斯、百克生物、万泰生物、智飞生物等跟跌。
美港电讯 · 08-14
A股生物制品持续下挫,康乐卫士跌近7%,智翔金泰、百普赛斯、百克生物、万泰生物、智飞生物等跟跌。
天风证券给予百克生物持有评级,水痘疫苗市占率高,带状疱疹疫苗放量潜力优秀
每日经济新闻 · 08-14
天风证券给予百克生物持有评级,水痘疫苗市占率高,带状疱疹疫苗放量潜力优秀
【企业动态】百克生物新增1件法院诉讼,案由为机动车交通事故责任纠纷
证券之星 · 08-09
【企业动态】百克生物新增1件法院诉讼,案由为机动车交通事故责任纠纷
百克生物:业绩说明会定于8月16日举行
每日经济新闻 · 08-08
百克生物:业绩说明会定于8月16日举行
A股成价值洼地,科创利好催化不断
鹏华基金 · 08-08
A股成价值洼地,科创利好催化不断
百克生物: 公司阿尔茨海默病治疗性疫苗项目目前处于临床前研究阶段,公司积极推进各项在研项目研发进展
证券之星 · 08-02
百克生物: 公司阿尔茨海默病治疗性疫苗项目目前处于临床前研究阶段,公司积极推进各项在研项目研发进展
公司概况
公司名称:
长春百克生物科技股份公司
所属行业:
医药制造业
上市日期:
2021-06-25
主营业务:
长春百克生物科技股份公司的主营业务是人用疫苗的研发、生产和销售。主要产品有水痘疫苗、鼻喷流感疫苗、带状疱疹疫苗。公司被持续认定为国家级“高新技术企业”。公司被吉林省科技厅认定为高新技术企业,批准设立“吉林省疫苗科技创新中心”、被吉林省发改委批准设立“吉林省疫苗工程研究中心”、被长春国家生物产业基地认定为“长春国家生物产业基地疫苗工程研究中心”、被吉林省工信厅认定为“省级企业技术中心”。
发行价格:
36.35
{"stockData":{"symbol":"688276","market":"SH","secType":"STK","nameCN":"百克生物","latestPrice":26.39,"timestamp":1723791600000,"preClose":29.29,"halted":0,"volume":8792934,"delay":0,"floatShares":413999999,"shares":413999999,"eps":1.2746,"marketStatus":"已收盘","marketStatusCode":5,"change":-2.9,"latestTime":"08-16 15:00:00","open":28.29,"high":28.29,"low":26.39,"amount":237000000,"amplitude":0.0649,"askPrice":26.39,"askSize":275,"bidPrice":26.38,"bidSize":25,"shortable":0,"etf":0,"ttmEps":1.2746,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724031000000},"adr":0,"adjPreClose":29.29,"symbolType":"stock_kcb","openAndCloseTimeList":[[1723771800000,1723779000000],[1723784400000,1723791600000]],"highLimit":32.22,"lowLimit":26.36,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":413657598,"pbRate":2.65,"roa":"--","roe":"3.37%","epsLYR":1.21,"committee":-0.804991,"marketValue":10916000000,"floatMarketCap":10916000000,"peRate":20.704534,"changeRate":-0.099,"turnoverRate":0.0213,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-08-19。","afterMarket":{"amount":0,"volume":0,"close":26.39,"buyVolume":0,"sellVolume":0,"time":1723793637153,"indexStatus":"已收盘 08-16 15:30:00","preClose":29.29}},"requestUrl":"/m/hq/s/688276/wiki","defaultTab":"wiki","newsList":[{"id":"2460220249","title":"百克生物(688276)2024年中报简析:营收净利润同比双双增长,应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2460220249","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460220249?lang=zh_cn&edition=full","pubTime":"2024-08-17 06:07","pubTimestamp":1723846030,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期百克生物发布2024年中报。截至本报告期末,公司营业总收入6.18亿元,同比上升10.5%,归母净利润1.38亿元,同比上升23.54%。按单季度数据看,第二季度营业总收入3.48亿元,同比下降8.44%,第二季度归母净利润7703.94万元,同比下降17.16%。本报告期百克生物应收账款上升,应收账款同比增幅达66.5%。筹资活动产生的现金流量净额变动幅度为164.61%,原因:本报告期增加银行借款。其他收益变动幅度为78.79%,原因:本报告期收到的政府补助资金增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081700011252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688276"],"gpt_icon":0},{"id":"2459129959","title":"百克生物: 未来公司如有回购相关事项,公司将及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2459129959","media":"证星董秘互动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459129959?lang=zh_cn&edition=full","pubTime":"2024-08-16 18:01","pubTimestamp":1723802469,"startTime":"0","endTime":"0","summary":"未来公司如有回购相关事项,公司将及时履行信息披露义务。百克生物董秘:尊敬的投资者您好,公司已于2024年8月16日披露《长春百克生物科技股份公司2024年半年度报告》,详细信息请关注公司定期报告,感谢您的关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816180347959e6711&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816180347959e6711&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688276"],"gpt_icon":0},{"id":"2459729828","title":"百克生物:8月16日接受机构调研,中信医药、国信医药等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2459729828","media":"证星公司调研","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459729828?lang=zh_cn&edition=full","pubTime":"2024-08-16 17:04","pubTimestamp":1723799040,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年8月16日百克生物发布公告称公司于2024年8月16日接受机构调研,中信医药、国信医药、华安医药、华源医药、华福医药、民生医药、申万医药、西南医药、兴业医药、信达医药、中银医药、东北医药、中金公司、投资者、东方医药、方正医药、国海医药、国金医药、国联医药、国投医药、国盛医药参与。同时,公司也在研发重组带状疱疹疫苗,目前该项目已提交Pre-IND。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408161705219f30a50e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408161705219f30a50e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159938","688276","BK0239"],"gpt_icon":0},{"id":"2459724264","title":"8月16日百克生物创60日新低,招商前沿医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2459724264","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459724264?lang=zh_cn&edition=full","pubTime":"2024-08-16 16:12","pubTimestamp":1723795977,"startTime":"0","endTime":"0","summary":"证券之星消息,8月16日百克生物跌9.90%创60日新低,收盘报26.39元,换手率2.13%,成交量8.79万手,成交额2.37亿元。重仓百克生物的公募基金请见下表:该股最近90天内共有3家机构给出评级,买入评级2家,中性评级1家;过去90天内机构目标均价为43.49。根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共3家,其中持有数量最多的公募基金为招商前沿医疗保健股票A。该公募基金现任基金经理为李佳存。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081600031802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688276","BK0239"],"gpt_icon":0},{"id":"2459239095","title":"北向资金8月15日净卖出百克生物14.36万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2459239095","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459239095?lang=zh_cn&edition=full","pubTime":"2024-08-16 09:30","pubTimestamp":1723771836,"startTime":"0","endTime":"0","summary":"8月15日,北向资金减持百克生物14.36万股连续3日减持。截止当日收盘,沪股通共持有百克生物167.03万股,占流通股0.40%。沪股通减持金额前五个股分别为上海贝岭、XD工业富、中国核电、韦尔股份、金龙汽车。百克生物近5个交易日下跌2.07%,沪股通累计减持44.57万股;近20个交易日下跌3.40%,沪股通累计增持68.16万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816093609959cf216&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816093609959cf216&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688276","BK0239"],"gpt_icon":0},{"id":"2459361342","title":"百克生物大跌5.05% 北向资金连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2459361342","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459361342?lang=zh_cn&edition=full","pubTime":"2024-08-16 09:30","pubTimestamp":1723771809,"startTime":"0","endTime":"0","summary":"08月16日,百克生物股价大幅下跌,截至09点30分,百克生物下跌5.05%,报27.81元/股,成交645万元,换手率0.06%。北向资金方面,百克生物08月15日获得北向资金减持14.36万股连续3日减持,截至08月15日,北向资金当前共持有百克生物167.03万股,市值4645万元,持股占流通股比为0.40%。最新财报显示,今年中报,百克生物实现营业收入6.18亿元,同比增长10.50%,净利润为1.38亿元,同比增长23.54%,基本每股收益为0.33元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816093027ab5df05c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816093027ab5df05c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688276","BK0239"],"gpt_icon":0},{"id":"2459485524","title":"图解百克生物中报:第二季度单季净利润同比减17.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459485524","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459485524?lang=zh_cn&edition=full","pubTime":"2024-08-15 17:10","pubTimestamp":1723713055,"startTime":"0","endTime":"0","summary":"证券之星消息,百克生物2024年中报显示,公司主营收入6.18亿元,同比上升10.5%;归母净利润1.38亿元,同比上升23.54%;扣非净利润1.35亿元,同比上升27.13%;其中2024年第二季度,公司单季度主营收入3.48亿元,同比下降8.44%;单季度归母净利润7703.94万元,同比下降17.16%;单季度扣非净利润7550.21万元,同比下降14.44%;负债率19.8%,投资收益22.62万元,财务费用-282.82万元,毛利率87.91%。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081500035279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688276"],"gpt_icon":0},{"id":"2459410487","title":"百克生物(688276)6月30日股东户数1.11万户,较上期增加33.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459410487","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459410487?lang=zh_cn&edition=full","pubTime":"2024-08-15 17:01","pubTimestamp":1723712471,"startTime":"0","endTime":"0","summary":"证券之星消息,近日百克生物披露,截至2024年6月30日公司股东户数为1.11万户,较3月31日增加2790.0户,增幅为33.46%。在生物制品行业个股中,百克生物股东户数低于行业平均水平,截至6月30日,生物制品行业平均股东户数为3.37万户。从股价来看,2024年3月31日至2024年6月30日,百克生物区间跌幅为35.77%,在此期间股东户数增加2790.0户,增幅为33.46%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081500034162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688276","BK0239"],"gpt_icon":0},{"id":"2459741284","title":"百克生物公布半年报 上半年净利增加23.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459741284","media":"智能小浪","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459741284?lang=zh_cn&edition=full","pubTime":"2024-08-15 16:20","pubTimestamp":1723710000,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 8月15日消息,百克生物发布半年度报告。 公告显示,公司半年度营业收入618,401,246.78元,同比增加10.5%,归属上市公司股东的净利润137,604,496.66元,同比增加23.54%。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:小浪快报","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2024-08-15/doc-incithkh6689763.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-08-15/doc-incithkh6689763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688276","BK0239"],"gpt_icon":0},{"id":"2459414839","title":"百克生物最新公告:上半年净利润同比增长23.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459414839","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459414839?lang=zh_cn&edition=full","pubTime":"2024-08-15 16:13","pubTimestamp":1723709612,"startTime":"0","endTime":"0","summary":"百克生物披露2024年半年度报告,公司实现营业收入6.18亿元,同比增长10.50%;归属于上市公司股东的净利润1.38亿元,同比增长23.54%。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081500031524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688276"],"gpt_icon":0},{"id":"2459416454","title":"百克生物(688276.SH)发布上半年业绩,净利润1.38亿元,增长23.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459416454","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459416454?lang=zh_cn&edition=full","pubTime":"2024-08-15 15:40","pubTimestamp":1723707613,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百克生物(688276.SH)发布2024年半年度报告,报告期内,公司实现营业收入6.18亿元,同比增长10.50%。实现归属于上市公司股东的净利润1.38亿元,同比增长23.54%。实现归属于上市公司股东的扣除非经常性损益的净利润1.35亿元,同比增长27.13%。基本每股收益0.33元。报告期内,公司始终秉承创新为企业基础生命力的理念,着力优化研发项目管理机制,建立了有效的预警机制、阶段性报告机制等,统筹布局长期、中期、短期研发项目。聚焦创新性疫苗、单克隆抗体等公司优势产品,实现生产一代、研发一代、储备一代,研发投入8,552.99万元,占营业收入13.83%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1164542.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688276"],"gpt_icon":0},{"id":"2459416141","title":"【百克生物:2024年上半年净利润同比增长23.54%】金十数据8月15日讯,百克生物公告,公司2024年上半年实现营业收入6.","url":"https://stock-news.laohu8.com/highlight/detail?id=2459416141","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459416141?lang=zh_cn&edition=full","pubTime":"2024-08-15 15:39","pubTimestamp":1723707594,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0239","688276"],"gpt_icon":0},{"id":"2459841695","title":"百克生物:2024年上半年净利润同比增长23.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459841695","media":"财通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459841695?lang=zh_cn&edition=full","pubTime":"2024-08-15 15:38","pubTimestamp":1723707480,"startTime":"0","endTime":"0","summary":"百克生物公告,公司2024年上半年实现营业收入6.18亿元,同比增长10.50%;实现归属于上市公司股东的净利润1.38亿元,同比增长23.54%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151539089f2cf285&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151539089f2cf285&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688276"],"gpt_icon":0},{"id":"2459646693","title":"生物疫苗概念盘中拉升,博晖创新涨3.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459646693","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459646693?lang=zh_cn&edition=full","pubTime":"2024-08-15 10:26","pubTimestamp":1723688770,"startTime":"0","endTime":"0","summary":"08月15日,生物疫苗概念盘中拉升,截至10点26分,生物疫苗概念整体指数上涨1.08%,报1744.630点。从个股上来看,该概念的成分股中,博晖创新涨3.80%,康希诺、百克生物、德展健康涨幅居前。从资金上来看,截止发稿,生物疫苗概念主力净流入为-5510.25万,其中百克生物受到资金热捧,主力净流入659.52万;拉长时间线来看,该板块近20日主力资金净流入-33.13亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815102610af977037&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815102610af977037&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0251","688276","BK0239","159657","BK0048","300318"],"gpt_icon":0},{"id":"2459916748","title":"A股生物制品持续下挫,康乐卫士跌近7%,智翔金泰、百普赛斯、百克生物、万泰生物、智飞生物等跟跌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2459916748","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459916748?lang=zh_cn&edition=full","pubTime":"2024-08-14 10:07","pubTimestamp":1723601273,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["301080","688443","LU1064131003.USD","LU1328615791.USD","BK0046","LU2148510915.USD","BK0188","BK0239","300122","09633","688276","BK0077","BK1200","399300","603392","BK1589","BK0216","BK0196","LU1981816686.USD","LU1064130708.USD","159982"],"gpt_icon":0},{"id":"2459637841","title":"天风证券给予百克生物持有评级,水痘疫苗市占率高,带状疱疹疫苗放量潜力优秀","url":"https://stock-news.laohu8.com/highlight/detail?id=2459637841","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459637841?lang=zh_cn&edition=full","pubTime":"2024-08-14 08:09","pubTimestamp":1723594153,"startTime":"0","endTime":"0","summary":"天风证券08月14日发布研报称,给予百克生物(688276.SH,最新价:29.57元)持有评级。评级理由主要包括:1)水痘疫苗市场有望扩容,公司产品居市场领先地位;2)国产首款带状疱疹疫苗上市,有望较快放量;3)鼻喷疫苗具有独特优势,发展前景值得期待。风险提示:长期技术迭代风险、核心技术泄密或被侵权的风险、产品安全性导致的潜在风险、市场竞争加剧的风险、行业政策变动风险、新产品上市销售不及预期的风险、测算具有主观性风险。文章来源:每日经济新闻原标题:天风证券给予百克生物持有评级,水痘疫苗市占率高,带状疱疹疫苗放量潜力优秀","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081408191195969096&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081408191195969096&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["601162","688276","159646"],"gpt_icon":0},{"id":"2458371849","title":"【企业动态】百克生物新增1件法院诉讼,案由为机动车交通事故责任纠纷","url":"https://stock-news.laohu8.com/highlight/detail?id=2458371849","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458371849?lang=zh_cn&edition=full","pubTime":"2024-08-09 06:18","pubTimestamp":1723155499,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,8月8日百克生物(688276)新增1件法院诉讼如下:案号:(2024)辽0123民初2722号法院:康平县人民法院案由:机动车交通事故责任纠纷原告:长春市永春汽车发运有限责任公司被告:长春百克生物科技股份公司、中国大地财产保险股份有限公司长春市中心支公司案件类型:民事立案日期:2024年8月8日数据来源:企查查以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080900010788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688276"],"gpt_icon":0},{"id":"2457936895","title":"百克生物:业绩说明会定于8月16日举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2457936895","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457936895?lang=zh_cn&edition=full","pubTime":"2024-08-08 16:12","pubTimestamp":1723104748,"startTime":"0","endTime":"0","summary":"每经AI快讯,百克生物8月8日晚间发布公告称,公司2024年半年度业绩说明会定于2024年8月16日上午09:00-10:00,以上证路演中心网络互动的形式进行。出席本次业绩说明会的人员有:董事、总经理孔维董事,常务副总经理姜春来,独立董事刘静,董事会秘书张喆,财务总监孟昭峰。2023年1至12月份,百克生物的营业收入构成为:生物医药占比99.99%。每经头条(nbdtoutiao)——中国版“星链”成功发射首批组网星!预计今年发射108颗低轨卫星,最终规模达到上万颗(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408081612549f19ca7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408081612549f19ca7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688276"],"gpt_icon":0},{"id":"2457804145","title":"A股成价值洼地,科创利好催化不断","url":"https://stock-news.laohu8.com/highlight/detail?id=2457804145","media":"鹏华基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457804145?lang=zh_cn&edition=full","pubTime":"2024-08-08 06:55","pubTimestamp":1723071313,"startTime":"0","endTime":"0","summary":"A股几大指数周三早盘基本上也是以红盘运行。外围市场剧烈动荡是A股市场最好的试金石,在近两周亚太市场普遍重挫的背景下,港股与A股都表现的较为坚韧。消息面上,近期科创相关催化不断。科创板的上市公司在A股市场中具有更强的研发能力以及成长性而备受市场关注,而在当下随着市场行情的不断调整,其投资性价比也与日俱增。周三市场反弹,科创100指数上涨超5%,可见其弹性之高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808065300aefdc14e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808065300aefdc14e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688582","688700","399300","688002","688425","688208","688343","688318","688278","688526","688327","688772","688798","688536","688568","688110","688608","688484","688361","688007","688032","688322","688789","688248","688779","688172","688192","688331","688516","688016","689009","688617","688347","688066","688050","688739","688161","688019","688383","688639","688166","688333","688001","688439","688498","688266","688575","688139","688690","688055","688326","688106","688107","688177","688100","688387","159982","688006","688520","688289","688005","688336","688778","688017","688276","688097","688578","688029","688366","688037","588220","688088","688200","688567","688408","688198","688556","688432","688409","688686","688083","688213","688052","688281","688235"],"gpt_icon":0},{"id":"2456470539","title":"百克生物:\n公司阿尔茨海默病治疗性疫苗项目目前处于临床前研究阶段,公司积极推进各项在研项目研发进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2456470539","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456470539?lang=zh_cn&edition=full","pubTime":"2024-08-02 18:00","pubTimestamp":1722592837,"startTime":"0","endTime":"0","summary":"证券之星消息,百克生物(688276)08月02日在投资者关系平台上答复投资者关心的问题。投资者:公司在稳步推进阿尔茨海默病相关诊断、治疗性疫苗等产品研发工作,现在进展到什么程度了,有进入临床实验阶段吗?百克生物董秘:尊敬的投资者您好,公司阿尔茨海默病治疗性疫苗项目目前处于临床前研究阶段,公司积极推进各项在研项目研发进展,感谢您的关注。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080200038953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159646","BK0239","688276"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-06-25","address":"吉林省长春市朝阳区高新开发区火炬路1260号","stockEarnings":[{"period":"1week","weight":-0.1051},{"period":"1month","weight":-0.1319},{"period":"3month","weight":-0.3128},{"period":"6month","weight":-0.4999},{"period":"1year","weight":-0.5268},{"period":"ytd","weight":-0.5165}],"companyName":"长春百克生物科技股份公司","boardCode":"AI0027","perCapita":"37172股","boardName":"医药制造业","registeredCapital":"41365万元","compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0282},{"period":"3month","weight":-0.0871},{"period":"6month","weight":0.0047},{"period":"1year","weight":-0.0899},{"period":"ytd","weight":-0.0321}],"survey":" 长春百克生物科技股份公司的主营业务是人用疫苗的研发、生产和销售。主要产品有水痘疫苗、鼻喷流感疫苗、带状疱疹疫苗。公司被持续认定为国家级“高新技术企业”。公司被吉林省科技厅认定为高新技术企业,批准设立“吉林省疫苗科技创新中心”、被吉林省发改委批准设立“吉林省疫苗工程研究中心”、被长春国家生物产业基地认定为“长春国家生物产业基地疫苗工程研究中心”、被吉林省工信厅认定为“省级企业技术中心”。","serverTime":1723878618310,"listedPrice":36.35,"stockholders":"11128人(较上一季度增加33.46%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百克生物(688276)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百克生物(688276)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百克生物,688276,百克生物股票,百克生物股票老虎,百克生物股票老虎国际,百克生物行情,百克生物股票行情,百克生物股价,百克生物股市,百克生物股票价格,百克生物股票交易,百克生物股票购买,百克生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百克生物(688276)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百克生物(688276)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}